Loading
₹2,282.30
−28.70−1.24%today
Market closed · 7 Oct, 3:30 pm
+16.29%over 1 year
Today's range
₹2,274.40₹2,326.80
52-week range
₹1,792.60₹2,537.60
Revenue and net profit in ₹ crore, consolidated where the company reports both.
| Year | Revenue | Net profit | Margin | EPS (₹) |
|---|---|---|---|---|
| FY26 | 16,711 | 1,362 | 8.1% | 48.24 |
| FY25 | 13,146 | 1,047 | 8.0% | 37.11 |
| FY24 | 11,635 | −1,502 | -12.9% | -53.22 |
| FY23 | 11,432 | 297 | 2.6% | 10.53 |
As of Jun 2026, as a share of all the company's shares.
| Holder | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 46.65% | 46.65% | 46.65% | 46.65% |
| FIIs | 20.89% | 20.34% | 19.20% | 20.73% |
| DIIs | 18.60% | 19.29% | 20.09% | 18.61% |
| of which mutual funds | 16.76% | 16.80% | 17.86% | 16.31% |
| Government | 0.04% | 0.04% | 0.04% | 0.04% |
| Public | 13.81% | 13.68% | 14.02% | 13.97% |
From the company's quarterly filings with NSE. FIIs are foreign institutions; DIIs are Indian ones such as mutual funds, insurers and banks.
Healthcare companies in the Nifty 500 closest in size.
| Company | Price (₹) | Change | Market cap (₹ cr) |
|---|---|---|---|
| Glenmark Pharmaceuticals Ltd.GLENMARK · this stock | 2,282.30 | −1.24% | 64,412 |
| Alkem Laboratories Ltd.ALKEM | 5,350.50 | +1.11% | 63,973 |
| Aster DM Quality Care Ltd.ASTERDM | 680.10 | −0.67% | 59,282 |
| Fortis Healthcare Ltd.FORTIS | 779.10 | +1.98% | 58,819 |
| Biocon Ltd.BIOCON | 360.00 | −2.47% | 58,669 |
| Abbott India Ltd.ABBOTINDIA | 26,100.00 | −0.06% | 55,461 |
| Gland Pharma Ltd.GLAND | 3,159.00 | +5.09% | 52,127 |
Price and volume from NSE; key figures and results from Yahoo Finance; shareholding and corporate actions from the company's NSE filings. Figures can run behind the exchange. For information only, not a recommendation to invest.